Drug Approval | December 28, 2024
Shilpa Medicare's Unit IV receives Eurasia GMP approval
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
The company has received the GMP Certification after successful closure of the inspection
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
The inspection conducted by EDQM at its Visakhapatnam facility
The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
This strong performance was primarily on account of a one-time gain from the strategic collaboration between Biocon Biologics and Eris Lifesciences.
The Unit has been issued GMP Certification from ANVISA-Brazil
Renews GMP certifications for India and Malaysia sites
A five-day inspection was concluded successfully with no critical and no major observations raised
Subscribe To Our Newsletter & Stay Updated
